US2019314459A1PendingUtilityA1

Treatment of hormonal disorders of growth

Assignee: US HEALTHPriority: Nov 12, 2014Filed: Jun 3, 2019Published: Oct 17, 2019
Est. expiryNov 12, 2034(~8.3 yrs left)· nominal 20-yr term from priority
A61P 5/06A61P 35/00A61K 38/1709C12N 2310/14A61K 31/48C12N 2310/11C12N 15/1138A61K 38/12A61K 38/31A61K 31/437A61K 31/713A61K 31/473C07K 14/705A61K 38/27C07K 16/28A61K 47/60C07K 14/723A61K 31/352C12N 15/8509A01K 67/0275
38
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention refers to a GPR101 inhibitor, antagonist or inverse agonist or inverse agonist for use in preventive and/or therapeutic treatment of diseases selected from the group consisting of acromegaly and gigantism and to methods for preventive and/or therapeutic treatment of diseases selected from the group consisting of acromegaly and gigantism. Further, the present invention provides a GPR101 agonist for use in preventive and/or therapeutic treatment of disorders selected from the group consisting of dwarfism, short stature, hypopituitarism and a disease of low levels of pituitary hormone secretion and to methods for preventive and/or therapeutic treatment of diseases selected from the group consisting of dwarfism, short stature, hypopituitarism and a disease of low levels of pituitary hormone secretion wherein to a subject GPR101 agonist is administered.

Claims

exact text as granted — not AI-modified
1 . A non-human transgenic animal, comprising an expressed transgene encoding GPR101. 
     
     
         2 . The non-human transgenic animal according to  claim 1 , wherein the transgene comprises the nucleic acid sequence shown in SEQ ID NO: 1, or encodes a protein having the amino acid sequence shown in SEQ ID NO: 2. 
     
     
         3 . The non-human transgenic animal according to  claim 1 , wherein the transgenic animal is a transgenic mammal. 
     
     
         4 . The non-human transgenic animal according to  claim 1 , wherein the animal is a chicken    
     
     
         5 . The non-human transgenic animal according to  claim 1 , wherein the animal is a cow or a pig. 
     
     
         6 . The non-human transgenic animal of  claim 1 , wherein the animal has increased body ma    
     
     
         7 . A method of increasing body mass and/or body size of a livestock comprising:
 administering to the livestock an effective amount of GPR101 agonist, or a GPR01 protein, thereby increasing body mass and/or body size of the livestock.   
     
     
         8 . The method according to  claim 7 , wherein the livestock is a chicken, a goose, a duck, a turkey, a pheasant, a pig, a cow, a sheep, or a goat. 
     
     
         9 . The method of  claim 7 , wherein the method increases body mass of the livestock. 
     
     
         10 . The method of  claim 7 , wherein the method increases body size of the livestock.

Join the waitlist — get patent alerts

Track US2019314459A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.